Abstract
Background: Amantadine is a drug that can help in the prevention of SARS-CoV-2 symptomatology, as has been demonstrated in observational clinical studies. Methods: We searched in the PubMed database Clinical Studies of coronavirus-infected patients who have been treated with amantadine in a preventive manner as well as patients with Parkinson’s disease. Results: Four clinical studies were found in which relatives of patients with COVID-19 had been prescribed the use of amantadine in a preventive manner to avoid the symptoms caused by the coronavirus. Conclusion: Amantadine is a drug that can be prescribed as a prophylactic that prevents symptomatology caused by SARS-CoV-2 coronavirus.
Author supplied keywords
Cite
CITATION STYLE
Cortés-Borra, A., & Aranda-Abreu, G. E. (2021). Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2. Pharmacological Reports, 73(3), 962–965. https://doi.org/10.1007/s43440-021-00231-5
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.